Correlation Between Johnson Johnson and Chugai Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Chugai Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Chugai Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Chugai Pharmaceutical Co, you can compare the effects of market volatilities on Johnson Johnson and Chugai Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Chugai Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Chugai Pharmaceutical.
Diversification Opportunities for Johnson Johnson and Chugai Pharmaceutical
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Johnson and Chugai is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Chugai Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chugai Pharmaceutical and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Chugai Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chugai Pharmaceutical has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Chugai Pharmaceutical go up and down completely randomly.
Pair Corralation between Johnson Johnson and Chugai Pharmaceutical
Considering the 90-day investment horizon Johnson Johnson is expected to under-perform the Chugai Pharmaceutical. But the stock apears to be less risky and, when comparing its historical volatility, Johnson Johnson is 3.22 times less risky than Chugai Pharmaceutical. The stock trades about -0.25 of its potential returns per unit of risk. The Chugai Pharmaceutical Co is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest 2,388 in Chugai Pharmaceutical Co on September 16, 2024 and sell it today you would lose (241.00) from holding Chugai Pharmaceutical Co or give up 10.09% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Johnson Johnson vs. Chugai Pharmaceutical Co
Performance |
Timeline |
Johnson Johnson |
Chugai Pharmaceutical |
Johnson Johnson and Chugai Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Johnson Johnson and Chugai Pharmaceutical
The main advantage of trading using opposite Johnson Johnson and Chugai Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Chugai Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chugai Pharmaceutical will offset losses from the drop in Chugai Pharmaceutical's long position.Johnson Johnson vs. Emergent Biosolutions | Johnson Johnson vs. Bausch Health Companies | Johnson Johnson vs. Neurocrine Biosciences | Johnson Johnson vs. Teva Pharma Industries |
Chugai Pharmaceutical vs. Scilex Holding | Chugai Pharmaceutical vs. Merck Company | Chugai Pharmaceutical vs. Johnson Johnson | Chugai Pharmaceutical vs. Pfizer Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |